About Us
A global medical technology company, BrainsWay focuses on developing cutting-edge medical devices that help advance the field of mental healthcare. Our advanced flagship technology of Deep Transcranial Magnetic Stimulation (Deep TMS™) is expanding the treatment of mental health beyond what was thought possible.
Deep TMS treatment has been proven to offer significant results by directly stimulating deeper and broader areas of the brain, effectively treating conditions such as depression, anxious depression, obsessive-compulsive disorder, and smoking addiction.
With numerous clinical studies and a growing number of patients and healthcare providers attesting to its success, BrainsWay Deep TMS is boldly advancing the treatment of mental health disorders.
UPCOMING WEBINAR
Treatments
BrainsWay’s innovative treatment has been proven beneficial in treating a number of mental health conditions, thanks to its safety and efficacy.
Featured Treatments
Major Depressive Disorder (MDD) treatment
BrainsWay’s safe and effective Deep TMS is FDA-cleared to treat major depressive disorder (depression), offering patients a better quality of life.
Anxious Depression treatment
Our most recent FDA clearance is for the safe and effective reduction of comorbid anxiety symptoms in adult patients with depression.
Obsessive-Compulsive Disorder (OCD) treatment
BrainsWay introduces the first FDA-cleared (de novo) noninvasive medical device for the treatment of OCD.
Smoking Addiction treatment
BrainsWay’s latest treatment offering for short-term smoking cessation in adults, representing the first FDA clearance in the addiction space for any TMS device.
Our Treatments
Individuals looking for a therapy that works, and particularly treatment-resistant patients, can finally find relief thanks to BrainsWay Deep TMS:
Patients & Healthcare Providers
BrainsWay has revolutionized the treatment of depression, OCD, and smoking addiction. With BrainsWay’s unique therapy, you can regain a sense of well-being and enjoy a better quality of life in just a few weeks.
Patients & Healthcare Providers
BrainsWay seeks to ensure that mental health providers, referral partners, and patients have the support necessary to achieve their goals.
From numerous studies to gaining FDA clearance and the European CE mark, BrainsWay’s safe and effective Deep TMS therapy is at the forefront of mental health treatments that are offering patients a brighter future.
With more than 600 providers, BrainsWay can provide the care you need.
See all the latest news, events and in the media BrainsWay has to offer and everything in-between.
News September 20, 2022
BURLINGTON, Mass. and JERUSALEM, Sept. 20, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
In the media September 16, 2022
Policy change by Cigna to now begin covering Deep TMS for the treatment of obsessive-compulsive disorder,...
News September 14, 2022
Cigna® Issues Favorable Policy for Deep TMS to Address Medication-Resistant Obsessive-Compulsive Disorder BURLINGTON,...
See all the latest mental health education articles and FAQs from BrainsWay.
